Celgene Welcomes Jounce to its Immuno-Oncology Collaborators List with US$2.56 B Deal

By Jawala Prasad & Heather Cartwright

Pharma Deals Review: Vol 2016 Issue 8 (Table of Contents)

Published: 2 Aug-2016

DOI: 10.3833/pdr.v2016.i8.2179     ISSN: 1756-7874

Section: Research & Development



In the latest in a stream of immuno-oncology alliances, Celgene has partnered with start-up Jounce Therapeutics in a deal potentially worth up to US$2...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details